Skip to content
The GLP-1 Verdict
Menu
Ranked #88 · Grade C

Hers review

Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

Visit Hers Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $199/mo (starting dose, compounded)
Tirzepatide
From $299/mo (starting dose, plus a separate fee, brand-name)
Coverage
All 50 states
Brand-name
Yes

The scorecard

Hers scored on our six published factors. See the methodology.

Real-world results75/100
Price honesty64/100
Prescriber access90/100
Formulary choice90/100
Cancellation fairness52/100
Member support70/100

What we like

  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The verdict

Best for: Shoppers who want mainstream telehealth GLP-1 access. Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

Ranked #88 of 499 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. On the board it sits between Heally, 74/100 above and Medsol RX at 74/100 below, with the Remote Pharmacy ruling the next one down.

Hers is one of 499 rulings on this board, which makes the fair next question who sits above it — our shortlist of Hers alternatives answers it in order, with every score shown. We have also ruled on it directly: CoreAge Rx vs Hers goes to CoreAge Rx, 94/100 to 74/100.

Visit Hers

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Hers's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Hers's site. Not medical advice; see our disclosure.

← Back to all rankings